Triple negative breast cancer (TNBC) represents about 17% of all breast carcinomas and it is characterized by the absence of the estrogen receptor (ER), the progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) [14]. Here, ERBB2 is linked to triple-negative breast carcinoma.